Amar D. Levens

An open-label randomised-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitis

Romée J.A.L.M. Snijders, Anna Stoelinga, Tom J.G. Gevers et al. · Journal of Hepatology · 2023 · 75 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Reliability and validity of an instrument for the assessment of bradykinesia

Thierry Q. Mentzel, Ritsaert Lieverse, Amar D. Levens et al. · Psychiatry Research · 2016 · 29 citations · Full text

Medicine, Neurology, Psychiatry +14

Assessing the efficacy and safety of mycophenolate mofetil versus azathioprine in patients with autoimmune hepatitis (CAMARO trial): study protocol for a randomised controlled trial

Romée J.A.L.M. Snijders, Anna E. C. Stoelinga, Tom J.G. Gevers et al. · Trials · 2022 · 12 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

Feasibility of Community Pharmacist-Initiated and Point-of-Care CYP2C19 Genotype-Guided De-Escalation of Oral P2Y12 Inhibitors

Amar D. Levens, Melina C. den Haan, J. Wouter Jukema et al. · Genes · 2023 · 11 citations · Full text

Medicine, Community Pharmacy, Pharmacology +17